VEGFA and cancer: For patients that have a lower survival, it is possible that these cancer-associated biological processes may have progressed beyond a point whereby subsequent treatment following surgery with anti-VEGF therapy is sufficient to enhance patient survival levels, likely by promoting treatment resistance mechanisms.